donepezil hydrochloride monohydrate
PolandDrugs containing this active substance
-
The medicine is used for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease, which is characterized by, among other things, memory loss, disorientation, and changes in behavior.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Biofarm Sp. z o.o.
-
The medicine is used for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease, which is characterized by, among other things, memory loss, disorientation, and changes in behavior.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Biofarm Sp. z o.o.
-
The medicine is used to treat symptoms of dementia in adults suffering from mild to moderate Alzheimer's disease. It helps with memory loss, disorientation, and changes in behavior.
Form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Biofarm Sp. z o.o.
-
It is used for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease, which is characterized by, among other things, memory loss, disorientation, and changes in behavior.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Accord Healthcare Polska Sp. z o.o.
-
The medicine is used for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease, which is characterized by, among other things, memory loss, disorientation, and changes in behavior.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Accord Healthcare Polska Sp. z o.o.
-
The medicine is intended for adults for the treatment of mild to moderate dementia in Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Bausch Health Poland Sp. z o.o. PharmaPath S.A.
-
The medicine is intended for adults for the treatment of mild to moderate dementia in Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Bausch Health Poland Sp. z o.o. PharmaPath S.A.
-
The medicine is intended for adults to treat symptoms of dementia (disorders of rational behavior) in individuals with diagnosed mild to moderate Alzheimer's disease.
Form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Bausch Health Poland Ltd.
-
The medicinal product is intended for the symptomatic treatment of mild to moderate dementia occurring in Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Celon Pharma S.A.
-
The medicine is intended for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Celon Pharma S.A.
-
The medicine is used to treat the symptoms of dementia in adults suffering from Alzheimer's disease in mild to moderate forms. It helps to alleviate symptoms such as memory loss, disorientation, and behavioral changes.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is intended for adults with mild to moderate Alzheimer's disease. It is used to alleviate symptoms such as memory loss, disorientation, and behavioral changes.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is intended for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease in adults.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is intended for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease in adults.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Ricordo is used to treat the symptoms of dementia (disorders of rational behavior) in adults with diagnosed Alzheimer's disease in mild to moderate forms.
Form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Adamed Pharma S.A.
-
Ricordo is used to treat the symptoms of dementia (disorders of rational behavior) in adults with diagnosed mild to moderate Alzheimer's disease.
Form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
Manufacturer: Adamed Pharma S.A.
-
The medicine is used for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease, which may manifest as memory loss, disorientation, and changes in behavior.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
Manufacturer: Krka, d.d., Novo mesto
-
It is used for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease, which may manifest as memory loss, disorientation, and behavioral changes.
Form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate up to 1 g ATC: N06DA02
Manufacturer: Krka, d.d., Novo mesto
-
The medicine is intended for adults for the treatment of dementia symptoms in individuals with mild to moderate Alzheimer's disease. It helps alleviate problems with memory, confusion, and behavioral changes.
Form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil hydrochloride monohydrate 5.22 mg ATC: N06DA02
Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH
-
The medicine is used to treat symptoms of dementia in adults with diagnosed mild to moderate Alzheimer's disease. It helps to alleviate memory problems, confusion, and behavioral changes.
Form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil hydrochloride monohydrate 10.43 mg ATC: N06DA02
Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH